Published in Am J Clin Pathol on June 01, 1974
Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals. J Clin Invest (1980) 2.07
Focal glomerular sclerosis in the fawn-hooded rat. Am J Pathol (1978) 1.18
Effect of aminonucleoside nephrosis on immune complex localization in autologous immune complex nephropathy in rats. J Clin Invest (1978) 1.08
Membrane attack complex deposition in experimental glomerular injury. Am J Pathol (1985) 1.07
Experimental glomerulonephritis in the isolated perfused rat kidney. J Clin Invest (1978) 4.45
On standard definitions: 33 years hence. Arch Dermatol (1997) 4.32
In situ immune complex formation and glomerular injury. Kidney Int (1980) 3.52
Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med (1993) 3.51
The highly effective use of topical zinc pyrithione in the treatment of psoriasis: a case report. Dermatol Online J (1997) 2.68
The nephrotic syndrome associated with secondary syphilis. An immune deposit disease. Am J Med (1970) 2.37
A new role for complement in experimental membranous nephropathy in rats. J Clin Invest (1980) 2.11
Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals. J Clin Invest (1980) 2.07
Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int (1992) 2.02
Review of the overall experience of captopril in hypertension. Arch Intern Med (1984) 1.99
Beneficial effects of methylprednisolone "pulse" therapy in diffuse proliferative lupus nephritis. Lancet (1976) 1.96
Transcriptional regulation of the tyrosine hydroxylase gene by glucocorticoid and cyclic AMP. Proc Natl Acad Sci U S A (1987) 1.81
New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest (1987) 1.75
Serum complement component levels in human glomerulonephritis. Ann Intern Med (1971) 1.70
Complement and the direct mediation of immune glomerular injury: a new perspective. Kidney Int (1985) 1.67
Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The Lupus Nephritis Collaborative Study Group. Am J Kidney Dis (1991) 1.66
Mechanisms of glomerular injury in immune-complex disease. Kidney Int (1985) 1.64
Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int (1991) 1.61
Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int (1999) 1.60
Survival data for patients undergoing chronic intermittent hemodialysis. Ann Intern Med (1969) 1.58
Crry, a complement regulatory protein, modulates renal interstitial disease induced by proteinuria. Kidney Int (1999) 1.57
Minimal change glomerulopathy associated with nonsteroidal antiinflammatory drugs. Am J Kidney Dis (1989) 1.55
Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int (2001) 1.52
Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis (2000) 1.50
Use of the serum creatinine to estimate glomerular filtration rate in health and early diabetic nephropathy. Collaborative Study Group of Angiotensin Converting Enzyme Inhibition in Diabetic Nephropathy. Am J Kidney Dis (1990) 1.49
Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med (1980) 1.47
Crescentic glomerulonephritis without immune deposits: clinicopathologic features. Kidney Int (1979) 1.45
The activated mesangial cell: a glomerular "myofibroblast"? J Am Soc Nephrol (1992) 1.44
Eosinophilia in the diagnosis of atheroembolic renal disease. Am J Nephrol (1987) 1.44
Giardia sp. cysts and infectious Cryptosporidium parvum oocysts in the feces of migratory Canada geese (Branta canadensis). Appl Environ Microbiol (1998) 1.43
Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int (1996) 1.43
Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells. J Clin Invest (1986) 1.42
Fish-oil-containing diet and platelet aggregation. Nutrition (1993) 1.42
Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am J Pathol (1995) 1.41
Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int (1995) 1.41
SPARC regulates the expression of collagen type I and transforming growth factor-beta1 in mesangial cells. J Biol Chem (1999) 1.40
Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization. Kidney Int (1991) 1.39
Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group. Am J Kidney Dis (1999) 1.37
Regulation of tyrosine hydroxylase mRNA by glucocorticoid and cyclic AMP in a rat pheochromocytoma cell line. Isolation of a cDNA clone for tyrosine hydroxylase mRNA. J Biol Chem (1983) 1.37
The human neutrophil serine proteinases, elastase and cathepsin G, can mediate glomerular injury in vivo. J Exp Med (1988) 1.35
Gamma G globulin subgroup composition of the glomerular deposits in human renal diseases. J Clin Invest (1970) 1.35
Prevalence of Cryptosporidium, Giardia and Eimeria infections in post-weaned and adult cattle on three Maryland farms. Vet Parasitol (2000) 1.34
Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. The Collaborative Study Group. Nephrol Dial Transplant (1998) 1.34
Role of intrinsic renal cells versus infiltrating cells in glomerular crescent formation. Kidney Int (1998) 1.33
Role of the terminal complement pathway in experimental membranous nephropathy in the rabbit. J Clin Invest (1983) 1.33
In vitro evidence for cellular hypersensitivity to glomerular-basement-membrane antigens in human glomerulonephritis. N Engl J Med (1970) 1.33
Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients. Am J Kidney Dis (1999) 1.33
Role of platelet-derived growth factor in glomerular disease. J Am Soc Nephrol (1993) 1.30
Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int (1990) 1.28
Intravenous pulse methylprednisolone therapy of acute crescentic rapidly progressive glomerulonephritis. Am J Med (1979) 1.27
The importance of sample size in the interpretation of the renal biopsy. Am J Nephrol (1988) 1.27
Survival of infectious Cryptosporidium parvum oocysts in seawater and eastern oysters (Crassostrea virginica) in the Chesapeake Bay. Appl Environ Microbiol (1998) 1.27
An immunopathologic study of rapidly progressive glomerulonephritis in the adult. Hum Pathol (1971) 1.27
Markers of complement-dependent and complement-independent glomerular visceral epithelial cell injury in vivo. Expression of antiadhesive proteins and cytoskeletal changes. Lab Invest (1992) 1.26
Circulating anticoagulants to factor VIII. Immunochemical studies and clinical response to factor VIII concentrates. Am J Med (1970) 1.26
Pulmonary hemorrhage in systemic lupus erythematosus. Medicine (Baltimore) (1978) 1.25
Glomerular deposition of tumor antigen in membranous nephropathy associated with colonic carcinoma. Am J Med (1974) 1.24
Chronic autologous immune complex glomerulopathy: effect of cyproheptadine. J Lab Clin Med (1974) 1.24
Detection of terminal complement components in experimental immune glomerular injury. Kidney Int (1984) 1.24
Idiopathic rapidly progressive glomerulonephritis. Am J Nephrol (1982) 1.23
Extraglomerular origin of the mesangial cell after injury. A new role of the juxtaglomerular apparatus. J Clin Invest (1997) 1.21
Potential Role of the Eastern Oyster, Crassostrea virginica, in the Epidemiology of Cryptosporidium parvum. Appl Environ Microbiol (1997) 1.21
Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy. J Immunol (1989) 1.21
Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group. Kidney Int (1996) 1.20
Platelets mediate neutrophil-dependent immune complex nephritis in the rat. J Clin Invest (1988) 1.20
Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy. J Clin Invest (1995) 1.20
Morphologic correlates of glomerular oxidant injury induced by the myeloperoxidase-hydrogen peroxide-halide system of the neutrophil. Lab Invest (1988) 1.20
Experimental glomerulonephritis in the mouse associated with mesangial deposition ofautologous ferritin immune complexes. Lab Invest (1975) 1.19
Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome. J Am Soc Nephrol (1999) 1.18
Studies of progressive glomerular sclerosis in the rat. Am J Pathol (1986) 1.18
Mesangial lesions and focal glomerular sclerosis in the aging rat. Lab Invest (1975) 1.17
Experimental glomerulonephritis in the guinea pig. I. Glomerular lesions associated with antiglomerular basement membrane antibody deposits. Lab Invest (1973) 1.16
Specific uptake of Heymann's nephritic kidney eluate by rat kidney: studies in vivo and in isolated perfused kidneys. Lab Invest (1982) 1.15
Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest (1992) 1.15
Occupational solvent exposure and glomerulonephritis. A case report and review of the literature. JAMA (1988) 1.14
Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo. Kidney Int (1997) 1.14
Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy. Kidney Int (1994) 1.14
Autologous immune complex nephropathy. I. Sequential study of immune complex deposition, ultrastructural changes, proteinuria, and alterations in glomerular sialoprotein. Lab Invest (1976) 1.13
Role of terminal complement pathway in the heterologous phase of antiglomerular basement membrane nephritis. Kidney Int (1985) 1.13
The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type 1 diabetic patients with nephropathy. The Collaborative Study Group. Am J Kidney Dis (1995) 1.12
Primary focal segmental glomerulosclerosis: clinical course and response to therapy. Am J Kidney Dis (1994) 1.11
Mesangial cell proliferation mediated by PDGF and bFGF is determined by levels of the cyclin kinase inhibitor p27Kip1. Kidney Int (1997) 1.11
An economic analysis of captopril in the treatment of diabetic nephropathy. The Collaborative Study Group. Diabetes Care (1996) 1.10
Renal autoregulation and vulnerability to hypertensive injury in remnant kidney. Am J Physiol (1987) 1.10
Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol (1995) 1.09
Participation of the myeloperoxidase-H2O2-halide system in immune complex nephritis. Kidney Int (1987) 1.09
Effect of aminonucleoside nephrosis on immune complex localization in autologous immune complex nephropathy in rats. J Clin Invest (1978) 1.08
Focal segmental glomerular sclerosis: the cellular lesion. Kidney Int (1985) 1.07
Membrane attack complex deposition in experimental glomerular injury. Am J Pathol (1985) 1.07
A homeodomain protein selectively expressed in noradrenergic tissue regulates transcription of neurotransmitter biosynthetic genes. J Neurosci (1995) 1.07
Trans-synaptic increase in RNA coding for tyrosine hydroxylase in a rat sympathetic ganglion. Brain Res (1985) 1.07
Thrombospondin 1 is expressed by proliferating mesangial cells and is up-regulated by PDGF and bFGF in vivo. Kidney Int (1995) 1.07
Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis. Am J Pathol (1992) 1.07
Immunotactoid glomerulopathy. Medicine (Baltimore) (1985) 1.06
A new model of renal microvascular endothelial injury. Kidney Int (1997) 1.06
Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain. Am J Pathol (1993) 1.06
Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J Clin Invest (1996) 1.06